Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company.

Medicare covers 80% of the cost for a CPAP machine and supplies if you have a specific type of sleep apnea. To get coverage for a CPAP machine, you have to show that you have sleep apnea through a ...

Zepbound (tirzepatide) is a prescription drug used to help with weight loss and sleep apnea in certain adults. The drug comes as a liquid solution inside vials or prefilled injection pens.

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher ... the FDA also green-lit it to treat moderate to severe sleep apnea. How Much Do the Vials Cost Now?

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

Lilly’s overall growth primarily is driven by sales of Zepbound, approved for obesity and sleep apnea, and Mounjaro, for Type 2 diabetes. Both drugs use the same active ingredient, tirzepatide.

Eligible patients diagnosed by a health-care provider with obesity alone or along with obstructive sleep apnea ... to pay for Zepbound themselves and are enrolled in Medicare or employer ...